Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation

AIMS: Non-vitamin K antagonist oral anticoagulants (NOACs) were in pivotal randomised controlled trials at least non-inferior to warfarin for stroke prevention in atrial fibrillation, but time in therapeutic range (TTR) for warfarin was lower (mean 55%–65%) than in Swedish general care where TTR is...

Descripción completa

Detalles Bibliográficos
Autores principales: Friberg, Leif, Oldgren, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Arrhythmias and Sudden Death
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623334/
https://www.ncbi.nlm.nih.gov/pubmed/29018536
http://dx.doi.org/10.1136/openhrt-2017-000682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623334/
https://www.ncbi.nlm.nih.gov/pubmed/29018536
http://dx.doi.org/10.1136/openhrt-2017-000682

Ejemplares similares